Types of Buyouts: The Seven Structures, and Who Owns the Company Afterward

There are seven buyout structures an owner of a lower-middle-market company is realistically likely to encounter: the leveraged buyout, the management buyout, the management buy-in, the secondary buyout, the employee buyout, the leveraged recapitalization, and the Independent Buyout. They differ on three things, and the multiple is not one of them: who puts up the equity, who ends up running the company, and how long you wait for the part of the price you did not collect at closing.

Every one of them is a "buyout" in the sense that borrowed money does most of the work. What changes is whose balance sheet carries the debt, whose name is on the equity, and whether you are the one financing your own exit.

What all buyouts have in common

A buyout is an acquisition of control funded mostly with debt raised against the company being acquired, rather than with the buyer's own cash. The scale is not marginal. Bain & Company's 2026 outlook reports global buyout investment "climbed sharply to $904 billion, a 44% increase over 2024" in 2025, with buyout-backed exit value up 47% to $717 billion.

The leverage is sized off cash flow. In the lower middle market, the Lincoln International senior debt data cited by CT Acquisitions puts median senior debt at 3.8x trailing twelve-month EBITDA, in a range of 3.0x to 5.0x. Price is sized off the same EBITDA: per GF Data's contributed set for the first nine months of 2025, purchase multiples ran 6.4x for $10-25 million enterprise values, 6.8x for $25-50 million, and 8.3x for $50-100 million.

So the arithmetic below uses one invented company throughout - $5,000,000 of adjusted EBITDA, no real-world counterpart - priced at 6.8x for $34,000,000 of enterprise value, with senior debt available at 3.8x, or $19,000,000. If you want your own starting number before reading further, the business valuation calculator will give you a sector-adjusted range, and how PE firms value a company explains the adjustments a buyer will make to the EBITDA figure you start from.

1. Leveraged buyout (LBO)

The default structure, and the one the other six are measured against. A private equity fund acquires control, places the acquisition debt on the company, contributes the remaining equity from the fund, and sells again at the end of a defined hold.

On the invented company: $34,000,000 of enterprise value, $19,000,000 of senior debt, $15,000,000 of buyer equity. The sponsor asks you to roll 20 percent of your proceeds - $6,800,000 - which cuts the fund's net new equity to $8,200,000 and leaves you $27,200,000 in cash at closing. How private equity actually finances a buyout takes that stack apart line by line.

The cash is the best of any structure here. The cost is the back end. Bain reports that "holding periods at exit are hovering around seven years, up from an average of five to six years from 2010 to 2021", with the industry "still sitting on 32,000 unsold companies worth $3.8 trillion" and distributions holding "below 15% of NAV for four years running". Your rolled $6,800,000 is liquid when the fund says it is, not when you need it - the mechanics are in rollover equity and the second bite.

2. Management buyout (MBO)

Your existing leadership team buys the company. MBOs ran roughly 14 percent of US lower-middle-market deal volume in 2025, and 41 percent of sub-$100 million transactions involved management somewhere on the buy-side cap table.

The constraint is always the same: the team cannot fund the equity. Price it at 5.0x rather than 6.8x and the invented company clears at $25,000,000. A conservative 3.0x of senior debt is $15,000,000, the team contributes $1,250,000 of personal capital, and the remaining $8,750,000 comes back to you as a subordinated seller note - $16,250,000 of cash at closing, or 65 percent of the price. Management buyout financing covers where each of those pieces comes from, and management buyout vs private equity runs the full side-by-side.

Two numbers belong in the decision. The first is performance: 22 percent of lower-middle-market MBOs closed between 2019 and 2021 traded below 1.0x invested equity at exit, against 15 percent of comparable sponsor-led LBOs - and you are a creditor of that outcome. The second is tax. A seller note makes you an installment seller under 26 U.S. Code § 453, and once the face amount outstanding at year end exceeds $5,000,000, § 453A charges you annual interest on the tax you deferred.

3. Management buy-in (MBI)

Same structure, different buyers: an outside executive or team acquires the company and installs itself as management. The distinction from an MBO is simply whether the buyer worked there before the deal.

For a seller, an MBI trades one risk for another. You are no longer negotiating against your own fiduciaries - the conflict that makes MBOs awkward - but you are selling to people who have never run this particular business and who almost always need a sponsor or a specialist lender standing behind them. That means more financing conditionality and a longer path to certainty of funds. Ask for proof of financing before you grant exclusivity, not after. A hybrid where an incoming executive buys alongside the existing team is sometimes called a BIMBO, and it inherits the diligence burden of both.

4. Secondary buyout

One private equity firm sells a portfolio company to another private equity firm. Nothing about the company's capital structure changes in kind - the debt is refinanced, a new sponsor's equity replaces the old, the hold clock resets.

This matters to a founder in exactly one way: it is frequently how your rollover equity actually gets monetized. If you sold to a sponsor and rolled, the "second bite" is often a sale to another fund rather than to a strategic buyer or the public market. The channel is under pressure. Bain's 2026 data has strategic exits growing 66 percent globally in 2025 against 21 percent for sponsor-to-sponsor sales, which is a long way of saying the buyer of last resort has been slower than the buyer of first resort. What happens after a private equity buyout follows that timeline year by year.

5. Employee buyout (ESOP)

A trust buys the company on behalf of the employees, funded with bank debt against the business plus seller notes for the balance. It is a real market, not a curiosity: the National Center for Employee Ownership counts 6,609 ESOPs at 6,411 companies - 5,993 of them private - covering 15.1 million participants and holding over $2 trillion in assets, on 2023 data.

Price is set by an independent appraiser at fair market value, which means no strategic premium, and the funding profile resembles the MBO more than the LBO: bank debt at the 3.0x-3.8x range above, with seller paper covering the gap. The offset is the tax code. Under 26 U.S. Code § 1042, a qualifying seller recognizes gain "only to the extent that the amount realized on such sale exceeds the cost to the taxpayer of such qualified replacement property" - deferral, not forgiveness - provided the plan holds "at least 30 percent" of the stock immediately after the sale and the proceeds are reinvested inside a replacement period that "begins 3 months before the date on which the sale of qualified securities occurs and which ends 12 months after".

6. Leveraged recapitalization

Not a change of control at all. The company borrows against its own cash flow and distributes the proceeds to its shareholders - you buy out part of yourself. At 3.0x on the invented company that is $15,000,000 in your hands while you keep 100 percent of the equity and the business carries the debt.

Sponsors have been leaning on this hard because exits have been slow. PE-backed companies issued $70.2 billion in leveraged loans earmarked for dividend recapitalizations through the first eleven months of 2025, with $43.6 billion paid out to sponsors as of December 8 - 24 percent above the prior post-crisis high of $35.1 billion set in 2021. The risk is undiluted: you have taken cash out and left the leverage behind, and if the business softens, the lender's claim is senior to your equity. A minority recapitalization does something similar with an outside investor's equity instead of debt, and selling part of the business while keeping control covers what the percentage actually decides.

7. Independent Buyout (IBO)

An Independent Buyout is built to take the financing capacity of the LBO and the governance of the MBO. The purchase is financed by borrowing against the company through a trust structure - sized off cash flow, the way a sponsor sizes a leveraged buyout, rather than off whatever the management team can raise personally. Existing leadership keeps running the business. There is no fund on the cap table, no consent list, and no exit clock, so the question of who the company gets sold to in year seven does not arise.

Because the buying entity is a trust, a qualifying sale can also be structured for the § 1042 deferral described above. Eligibility is fact-specific and belongs with a tax advisor rather than in a brochure.

The seven, side by side

Structure	Who buys	Who funds the equity	Control after closing	What you wait for
Leveraged buyout	A private equity fund	The fund, plus your rollover	Sponsor board and consent rights	Rollover equity, ~7 years
Management buyout	Your existing team	Bank, team savings, and you	Unchanged; bank covenants only	Seller note, 3-7 years
Management buy-in	An outside executive or team	Bank plus a backer behind them	New management installed	Seller note, plus financing risk
Secondary buyout	Another private equity fund	The incoming fund	New sponsor, new hold clock	Nothing - you are already out
Employee buyout (ESOP)	A trust for the employees	Bank debt plus seller notes	Unchanged; trustee oversight	Seller notes; § 1042 deferral
Leveraged recapitalization	Nobody - you keep the equity	Lenders only	Unchanged; more leverage	Nothing; the debt stays
Independent Buyout	A trust owned by employees	Debt sized off company cash flow	Unchanged; no sponsor, no clock	Structure-dependent; § 1042 may apply

How to read the list for your own company

Rank them on cash at closing and the order is roughly LBO, then recapitalization, then MBI, then ESOP and MBO. Rank them on control the day after closing and the order inverts almost exactly. There is no structure that is first on both lists, and any advisor who implies otherwise is selling one of them.

The practical sequence is to price the company before you pick a structure, because the price determines how much debt the business can carry and therefore which structures can actually fund themselves. Then decide what you need the money for and when - a founder who needs liquidity in year one and a founder who needs it in year eight should not be looking at the same page of this list. Business exit planning: every option sets the buyout structures against the paths that are not buyouts at all, and choosing an M&A advisory firm covers how to tell whether the person showing you options is paid to show you all of them.

Frequently asked questions

What is the difference between a buyout and an acquisition? An acquisition is any purchase of a company. A buyout is an acquisition of control financed mostly with debt raised against the target itself. A strategic buyer writing a check from its own balance sheet is making an acquisition, not a buyout.

What is a secondary buyout? A sale of a private-equity-owned company to another private equity firm. The company's leverage is refinanced, a new sponsor's equity comes in, and the holding period starts over. For a founder who rolled equity into the first deal, it is often the event that finally converts that stake to cash.

Which type of buyout pays the most? On headline price and cash at closing, the sponsor-led leveraged buyout, consistently. Lower-middle-market MBOs clear roughly 4x-6x EBITDA against sponsor platform pricing of 6.4x-8.3x by size tier. The question is what the gap buys - and what the structure costs you in control and in waiting.

Can an owner stay involved after a buyout? In every structure here except a clean sponsor exit, yes, and in most of them the buyer insists on it. The difference is the terms: a seller note makes you a creditor, rollover equity makes you a minority shareholder, and a board seat under a sponsor comes with a consent list attached.

Sources

• Bain & Company, "Private Equity Outlook 2026: Gaining Traction"
• CT Acquisitions, "What Is a Management Buyout (MBO)? 2026 Structural Guide"
• CapitalPad, "Lower Middle Market EBITDA Multiples" (GF Data, first nine months of 2025)
• National Center for Employee Ownership, "ESOPs by the Numbers"
• ABF Journal, "The Dividend Recap Surge: What Record Sponsor Payouts Reveal About the Exit Impasse"
• 26 U.S. Code § 1042 - Cornell Law School Legal Information Institute
• 26 U.S. Code § 453 - Cornell Law School Legal Information Institute
• 26 U.S. Code § 453A - Cornell Law School Legal Information Institute

The bottom line

Seven structures, one question underneath all of them: after the wire clears, who decides what happens to the company, and how much of the price is still owed to you by somebody else? The leveraged buyout pays the most cash and hands over the most control. The management buyout does the reverse and asks you to lend the difference. The Independent Buyout exists because those are not the only two shapes the financing can take.

If your company does $3M+ in EBITDA and you are trying to work out which of these structures your business can actually support, talk to IBO Advisors.